Please use this identifier to cite or link to this item: https://repositorio.ufrn.br/jspui/handle/123456789/25429
Title: In a Methotrexate-Induced Model of Intestinal Mucositis, Olmesartan Reduced Inflammation and Induced Enteropathy Characterized by Severe Diarrhea, Weight Loss, and Reduced Sucrose Activity
Authors: Araújo, Aurigena Antunes de
Borba, Pedro Brito
Souza, Fernando Henrique Destefani de
Nogueira, Anália Cristina
Saldanha, Taís Suassuna
Araújo, Thayse Emanuele Franklin
Silva, Aldemara Ingrid da
Araújo Júnior, Raimundo Fernandes de
Keywords: intestinal mucositis model;olmesartan;inflammation
Issue Date: 2015
Publisher: The Pharmaceutical Society of Japan
Citation: ARAÚJO, Aurigena Antunes de et al. In a Methotrexate-Induced Model of Intestinal Mucositis, Olmesartan Reduced Inflammation and Induced Enteropathy Characterized by Severe Diarrhea, Weight Loss, and Reduced Sucrose Activity. Biological & Pharmaceutical Bulletin, v. 38, p. 746-752, 2015. Disponível em: <https://www.jstage.jst.go.jp/article/bpb/38/5/38_b14-00847/_article>. Acesso em: 20 mar. 2018.
Portuguese Abstract: The aim of this study was to evaluate the effect of olmesartan (OLME), an angiotensin II receptor antagonist, on an intestinal mucositis model. Briefly, daily intraperitoneal (i.p.) injections of methotrexate (MTX) 7 mg/kg were administered to rats on 3 consecutive days. A subset of these rats was also pretreated with oral administration of OLME (0.5, 1.0, or 5.0 mg/kg) or vehicle as a control 30 min prior to MTX injection. Body weight, feces scoring, and death were recorded daily. On day 4, the rats were killed, and intestinal tissues were assayed for levels of interleukin (IL)-1β and tumor necrosis factor (TNF)-α, myeloperoxidase and sucrose activity, and histopathological findings. A significant reduction in body weight was observed in the MTX+1.0 mg/kg OLME group (p<0.01). The feces scores for the MTX+0.5 mg/kg OLME and MTX+5.0 mg/kg OLME groups were also significantly higher (p<0.001). Sucrose activity was reduced in all groups treated with OLME (p<0.05). Treatment with MTX+OLM at all doses resulted in reduced inflammatory infiltration, ulcerations, vasodilation, and hemorrhagic areas (p<0.05), as well as reduced concentrations of myeloperoxidase (p<0.001). The IL-1β and TNF-α levels were decreased in the MTX+OLME 5.0 mg/kg (p<0.01 and p<0.05, respectively) compared with the MTX-alone group. Overall, antiinflammatory activity was observed in rats with MTX-induced intestinal mucositis that were administered OLME. However, further studies are needed to elucidate the adverse effects of OLME.
URI: https://repositorio.ufrn.br/jspui/handle/123456789/25429
ISSN: 1347-5215
Appears in Collections:CB - DBF - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
In a Methotrexate-Induced Model of Intestinal Mucositis_20153.pdf3,77 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.